Amy Wilson Selected Research

Amy Wilson Research Topics

Disease

6	Breast Neoplasms (Breast Cancer) 12/2021 - 01/2020
5	Neoplasms (Cancer) 11/2021 - 12/2007
4	Pathologic Complete Response 12/2021 - 01/2020
2	Triple Negative Breast Neoplasms 12/2021 - 01/2020
2	Hypertension (High Blood Pressure) 01/2017 - 06/2005
2	Sleep Initiation and Maintenance Disorders (Insomnia) 04/2011 - 02/2010
1	Rupture 12/2021
1	Hyperglycemia 10/2021
1	COVID-19 04/2021
1	Hypersensitivity (Allergy) 11/2020
1	Leukopenia 11/2017
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2017
1	Masked Hypertension 01/2017
1	Mental Disorders (Mental Disorder) 01/2016
1	Lymphoma (Lymphomas) 08/2014
1	Disease Progression 08/2012
1	Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy) 08/2012
1	Urinary Incontinence 07/2012
1	Major Depressive Disorder (Major Depressive Disorders) 04/2011
1	Anxiety Disorders (Anxiety Disorder) 04/2011
1	Inflammation (Inflammations) 07/2010
1	Anhedonia 05/2010
1	Nasopharyngitis 02/2010
1	Headache (Headaches) 02/2010
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2008
1	Cardiac Arrhythmias (Arrythmia) 11/2008
1	Ellis-Van Creveld Syndrome (Chondroectodermal Dysplasia) 08/2007
1	Overweight 06/2005
1	Weight Loss (Weight Reduction) 06/2005
1	Stroke (Strokes) 01/2003
1	Myocardial Infarction 01/2003
1	Weight Gain 01/2002

Drug/Important Bio-Agent (IBA)

4	Hormones (Hormone)IBA 12/2021 - 01/2020
3	Paclitaxel (Taxol)FDA LinkGeneric 12/2021 - 10/2021
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021 - 10/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021 - 10/2021
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2020
2	Antihypertensive Agents (Antihypertensives)IBA 01/2017 - 06/2005
2	Eszopiclone (Lunesta)FDA Link 04/2011 - 02/2010
1	MicroplasticsIBA 12/2021
1	CosmeticsIBA 12/2021
1	OilsIBA 12/2021
1	durvalumabIBA 12/2021
1	olaparibIBA 12/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2021
1	Immune Checkpoint InhibitorsIBA 12/2021
1	Trastuzumab (Herceptin)FDA Link 11/2021
1	pertuzumabIBA 11/2021
1	Ado-Trastuzumab EmtansineIBA 11/2021
1	Metformin (Glucophage)FDA LinkGeneric 10/2021
1	Hemoglobins (Hemoglobin)IBA 10/2021
1	ganitumabIBA 10/2021
1	Pharmaceutical PreparationsIBA 10/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	MK 2206IBA 01/2020
1	pembrolizumabIBA 01/2020
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020
1	TOR Serine-Threonine KinasesIBA 01/2020
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 11/2017
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2016
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 08/2014
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 08/2014
1	Cytarabine (Cytosar-U)FDA LinkGeneric 08/2014
1	Colchicine FDA LinkGeneric 08/2014
1	tafamidisIBA 08/2012
1	Prealbumin (Transthyretin)IBA 08/2012
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 04/2011
1	Pyridinolcarbamate (P23)IBA 04/2011
1	Antidepressive Agents (Antidepressants)IBA 04/2011
1	Escitalopram FDA Link 04/2011
1	Fluoxetine (Prozac)FDA LinkGeneric 04/2011
1	Cell Surface ReceptorsIBA 07/2010
1	Indicators and Reagents (Reagents)IBA 05/2010
1	Formoterol Fumarate (Oxis)FDA Link 11/2008
1	Adrenergic Agents (Adrenergic Drugs)IBA 11/2008
1	Salmeterol Xinafoate (Serevent)FDA Link 11/2008
1	KinesinsIBA 12/2007
1	Chlorpromazine (Thorazine)FDA Link 12/2007
1	Proteins (Proteins, Gene)FDA Link 08/2007
1	Dietary SodiumIBA 06/2005
1	Dipyridamole (Persantine)FDA LinkGeneric 01/2003
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2003
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2003
1	Clopidogrel (Plavix)FDA Link 01/2003
1	CholesterolIBA 01/2002

Therapy/Procedure

6	Therapeutics 11/2021 - 12/2007
5	Neoadjuvant Therapy 12/2021 - 01/2020
2	Kidney Transplantation 11/2017 - 01/2017
1	Personal Protective Equipment 04/2021
1	Adjuvant Chemotherapy 01/2020
1	Transplantation 11/2017
1	Home Nursing (Nursing, Home) 07/2012
1	Secondary Prevention 01/2003